Tesamorelin vs Sermorelin: Which GH Peptide Is Right for You?
Medically reviewed by Medical Advisory Board Last reviewed 2026-05-13
FDA-approved GHRH analogs compared by evidence, cost, and use case
Both tesamorelin and sermorelin stimulate the pituitary to release growth hormone, but they differ significantly in clinical evidence, cost, and availability. Tesamorelin has stronger trial data; sermorelin is far more affordable and widely prescribed.
Tesamorelin and sermorelin are both FDA-approved GHRH analogs that stimulate the pituitary to release growth hormone — but they were developed for different indications, have different evidence bases, and are priced dramatically differently. Understanding these differences helps determine which is appropriate for a given patient.
Want expert help with your metabolic health?
We can match you with a metabolic-medicine specialist who understands this area — so you get the right doctor, not just any doctor.
Book An Appointment With A Specialist →Tesamorelin vs Sermorelin: Full Comparison
| Factor | Tesamorelin (Egrifta) | Sermorelin |
|---|---|---|
| FDA approval | Yes — HIV-associated lipodystrophy (2010) | Yes — pediatric GH deficiency (1997) |
| Mechanism | Modified GHRH analog (longer half-life) | GHRH 1-29 analog (natural sequence) |
| Half-life | ~26 minutes | ~12 minutes |
| Clinical evidence | Multiple Phase III RCTs (visceral fat, IGF-1) | Decades of off-label clinical use, observational data |
| Visceral fat data | 15–25% reduction in RCTs | Less studied, clinically observed |
| Brand name cost | $3,000–5,000/month | Off-patent; compounded $150–400/month |
| Access | Prescription required; limited compounding availability | Prescription required; widely compounded |
| Stacking | Usually standalone (no GHRP typically added) | Often stacked with ipamorelin for synergy |
Which to Choose
Choose tesamorelin if:
- You have HIV-associated lipodystrophy (FDA-indicated use)
- Visceral fat reduction is the primary goal and cost is not a barrier
- You're in an institutional setting where the FDA-approved agent is preferred
Choose sermorelin if:
- Cost is a consideration ($150–400/month compounded vs. $3,000–5,000/month for brand tesamorelin)
- You want to stack with a GHRP (ipamorelin) for synergistic GH stimulation
- You're working with a functional/anti-aging physician who is familiar with sermorelin protocols
- Broad GH optimization (not specifically visceral fat) is the goal
Frequently Asked Questions
Is tesamorelin better than sermorelin?
Tesamorelin has stronger clinical evidence (Phase III RCTs) specifically for visceral fat reduction. However, sermorelin is far more affordable, widely available through compounding pharmacies, and can be stacked with ipamorelin for synergistic GH stimulation. For most non-HIV patients, sermorelin (often with CJC-1295/ipamorelin) offers comparable GH optimization at a fraction of the cost.
What is the difference between tesamorelin and sermorelin?
Both are GHRH analogs that stimulate pituitary GH release. Key differences: tesamorelin has a slightly longer half-life, stronger Phase III trial evidence specifically for visceral fat, and is only FDA-approved for HIV lipodystrophy. Sermorelin has been used off-label for adult GH optimization for decades, costs dramatically less, and is more widely available through compounding pharmacies.
Topic updates
Get the weekly peptide roundup
Peptide therapy, GLP-1s, growth hormone peptides, healing peptides, safety notes, and comparison guides.
Check Where You Stand
Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Related Comparisons
-
Ipamorelin vs Sermorelin: GH Peptide Pathways, Dosing, and Which to Choose
Ipamorelin vs sermorelin: GHRP vs GHRH analog, mechanisms, dosing, and why they're stacked.
-
CJC-1295 vs Sermorelin: Which GHRH Analog to Choose and Why
CJC-1295 vs sermorelin: same GHRH receptor, different half-life and dosing frequency.
-
CJC-1295 vs Tesamorelin: FDA-approved GHRH Analog vs Longer-acting Unapproved Option
CJC-1295 vs tesamorelin: FDA-approved GHRH analog vs longer-acting unapproved option.
See more related comparisons
-
Sermorelin Alternatives: CJC-1295, Tesamorelin, Ipamorelin, MK-677, and Synthetic HGH Compared
Sermorelin alternatives ranked: CJC-1295, tesamorelin, ipamorelin, MK-677, and synthetic HGH.
-
Tesamorelin vs Ipamorelin: GHRH Analog vs Selective GHRP Compared
Tesamorelin vs ipamorelin: GHRH analog vs selective GHRP, often combined not substituted.
-
AOD-9604 vs Tesamorelin: Which Fat-loss Peptide Has Real Evidence?
AOD-9604 vs tesamorelin: failed obesity trial vs FDA-approved visceral-fat peptide.
-
Sermorelin: Anti-aging Growth Hormone Therapy Guide
Sermorelin therapy for HGH stimulation, aging, and body composition.